Note 8 - Fair Value Measurements - Equity Financing (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Aug. 27, 2024 |
Apr. 12, 2024 |
Oct. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Gross proceeds | $ 500,000 | $ 6,466,500 | |||
| Less: placement agent and legal fees | (778,261) | ||||
| Net proceeds | $ 0 | 5,688,239 | |||
| Less: Fair value of warrant liabilities at Issuance | (7,766,000) | (19,494,000) | |||
| Loss on equity financing | $ 15,305,761 | $ 0 | $ (15,305,761) | ||
| Series F Convertible Preferred Stock [Member] | |||||
| Less: Series F issued for Alpha consent (in shares) | (1,050) | (1,500,000) | |||
| X | ||||||||||
- Definition The gain (loss) on an equity offering. No definition available.
|
| X | ||||||||||
- Definition Amount of placement agent and legal fees. No definition available.
|
| X | ||||||||||
- Definition The net cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. No definition available.
|
| X | ||||||||||
- Definition Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|